Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A)

Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy

(2012) Jachinta E. Rooney et al.   AMERICAN JOURNAL OF PATHOLOGY

Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy2J/dy2J Mouse

(2011) Moran Elbaz et al.   ANNALS OF NEUROLOGY

Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases

(2011) Markus A. Rüegg et al.   Annual Review of Pharmacology and Toxicology

Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice

(2011) Sarina Meinen et al.   EMBO Molecular Medicine

Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A

(2011) A. Kumar et al.   HUMAN MOLECULAR GENETICS

Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A

(2011) Virginie Carmignac et al.   HUMAN MOLECULAR GENETICS

Losartan Decreases Cardiac Muscle Fibrosis and Improves Cardiac Function in Dystrophin-Deficient Mdx Mice

(2011) Christopher F. Spurney et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice

(2011) Lawrence T. Bish et al.   PLoS One

Role of TGF-β signaling in inherited and acquired myopathies

(2011) Tyesha N Burks et al.   Skeletal Muscle

Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice

(2010) Virginie Carmignac et al.   HUMAN MOLECULAR GENETICS

Transgenic overexpression of laminin α1 chain in laminin α2 chain-deficient mice rescues the disease throughout the lifespan

(2010) Kinga I. Gawlik et al.   MUSCLE & NERVE

Fibrosis inhibition and muscle histopathology improvement in laminin-α2-deficient mice

(2010) Yoram Nevo et al.   MUSCLE & NERVE

Omigapil Ameliorates the Pathology of Muscle Dystrophy Caused by Laminin- 2 Deficiency

(2009) M. Erb et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Non-Smad pathways in TGF-β signaling

(2008) Ying E Zhang   CELL RESEARCH

Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells

(2008) Morgan E. Carlson et al.   NATURE